Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods
暂无分享,去创建一个
Olav Jansen | Scott M Berry | Rishi Gupta | Roger J Lewis | Raul G Nogueira | Vitor Pereira | Kevin N Sheth | David S Liebeskind | Ryan Shields | Alain Bonafe | Marc Ribo | Jeffrey L Saver | Wade S. Smith | A. Rai | S. Hetts | D. Liebeskind | J. Saver | B. Baxter | R. Nogueira | R. Lewis | T. Malisch | D. Gress | K. Sheth | O. Jansen | A. Bonafe | A. Furlan | T. Jovin | S. Berry | V. Pereira | M. Ribó | Rishi Gupta | D. Lopes | T. Graves | Anthony Furlan | Tudor G Jovin | Demetrius Lopes | Blaise Baxter | Wade Smith | Daryl Gress | Steven Hetts | Todd L Graves | Tim Malisch | Ansaar Rai | Ryan Shields | A. Furlan
[1] Adnan H Siddiqui,et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.
[2] C. Molina,et al. Age-adjusted infarct volume threshold for good outcome after endovascular treatment , 2013, Journal of NeuroInterventional Surgery.
[3] D. Liebeskind,et al. Collaterals in endovascular therapy for stroke. , 2015, Current opinion in neurology.
[4] J. Grotta,et al. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale , 2015, Stroke.
[5] C. Molina,et al. Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion , 2016, Stroke.
[6] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[7] Roland Bammer,et al. Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME , 2016, Annals of neurology.
[8] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[9] S. Pedraza,et al. The clinical–DWI mismatch , 2004, Neurology.
[10] Jeffrey L Saver,et al. Quantifying the Value of Stroke Disability Outcomes: WHO Global Burden of Disease Project Disability Weights for Each Level of the Modified Rankin Scale , 2009, Stroke.
[11] M. Mlynash,et al. Pittsburgh Outcomes After Stroke Thrombectomy Score Predicts Outcomes After Endovascular Therapy for Anterior Circulation Large Vessel Occlusions , 2014, Stroke.
[12] K. Axhausen,et al. Quantifying the value of urban form , 2014 .
[13] D. Liebeskind,et al. Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials , 2016, Stroke.
[14] Hester F. Lingsma,et al. Letter by Mulder et al Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". , 2019, Stroke.
[15] H. Diener,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.
[16] Oliver Rivero-Arias,et al. Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] Manabu Inoue,et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.
[18] Jeffrey L Saver,et al. Optimal End Points for Acute Stroke Therapy Trials: Best Ways to Measure Treatment Effects of Drugs and Devices , 2011, Stroke.
[19] Catherine Oppenheim,et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial , 2016, The Lancet Neurology.
[20] Manabu Inoue,et al. Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue , 2015, Neurology.
[21] A. Demchuk,et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.
[22] Linda Worrall,et al. Clinical guidelines for acute stroke management , 2007 .
[23] Eric E. Smith,et al. Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015 , 2015, International journal of stroke : official journal of the International Stroke Society.
[24] Hester F. Lingsma,et al. A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.
[25] K. Hill. Australian Clinical Guidelines for Acute Stroke Management 2007 , 2008, International journal of stroke : official journal of the International Stroke Society.
[26] A. Demchuk,et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.
[27] C. Sorensen,et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke , 2015 .
[28] Eso Writing,et al. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 , 2008 .
[29] W. Copen,et al. Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. , 2009, Radiology.
[30] M. Krause,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.
[31] R. Higashida,et al. Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.
[32] A. Rai,et al. Imaging-Based Endovascular Therapy for Acute Ischemic Stroke due to Proximal Intracranial Anterior Circulation Occlusion Treated Beyond 8 Hours From Time Last Seen Well: Retrospective Multicenter Analysis of 237 Consecutive Patients , 2011, Stroke.